HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adinazolam sustained-release treatment of panic disorder: a double-blind study.

Abstract
Two hundred six outpatients with panic disorder and agoraphobia were randomly assigned to receive 4 weeks of treatment with placebo or sustained-release adinazolam under double-blind conditions. Eighty-eight percent of patients receiving drug and 85% of patients receiving placebo remained in the study at week 4. This report describes the "intent-to-treat" analysis of 202 patients who made at least one follow-up visit after randomization at baseline. On the basis of the Clinical Global Impressions-Improvement Scale, 69.7% of the adinazolam-treated patients were much or very much improved compared with 39.6% of the placebo-treated patients at week 4 or end-point (p = 0.0001). At week 4, panic attacks were completely blocked in 57.1% of adinazolam-treated patients and in 39.2% of the placebo-treated patients (p = 0.009). Adinazolam sustained-release treatment was statistically more effective than placebo treatment on measures of global improvement, number of panic attacks, SCL-90 phobia severity, main phobia severity, and anticipatory and general anxiety. No drug-placebo differences were found for overall self-rated phobia severity, unexpected or situational panic attacks, or for work, family, or social disability.
AuthorsJ R Davidson, B Beitman, J H Greist, R J Maddock, C P Lewis, A Q Sheridan, C Carter, K R Krishnan, M R Liebowitz, D G Haack
JournalJournal of clinical psychopharmacology (J Clin Psychopharmacol) Vol. 14 Issue 4 Pg. 255-63 (Aug 1994) ISSN: 0271-0749 [Print] United States
PMID7962681 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Anti-Anxiety Agents
  • Antidepressive Agents
  • Delayed-Action Preparations
  • Benzodiazepines
  • adinazolam
Topics
  • Adult
  • Agoraphobia (drug therapy, psychology)
  • Anti-Anxiety Agents
  • Antidepressive Agents (administration & dosage, adverse effects)
  • Benzodiazepines (administration & dosage, adverse effects)
  • Delayed-Action Preparations
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Drug Administration Schedule
  • Female
  • Humans
  • Male
  • Middle Aged
  • Panic Disorder (drug therapy, psychology)
  • Personality Assessment (statistics & numerical data)
  • Personality Inventory (statistics & numerical data)
  • Psychometrics
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: